Tyrosine kinase inhibitors containing a zinc binding moiety

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9169244
APP PUB NO 20140128410A1
SERIAL NO

13845885

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to tyrosine kinase inhibitors that contain a zinc-binding moiety and their use in the treatment of tyrosine related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • CURIS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cai, Xiong Bedford, US 99 1255
Gould, Stephen San Carlos, US 51 1331
Qian, Changgeng Wayland, US 72 738
Zhai, Haixiao Bedford, US 48 443

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 27, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00